Live attenuated vaccines are weakened by:
Live attenuated vaccines are weakened by serial passaging in non natural host cell cultures, tissues or under suboptimal temperature forcing accumulation of adaptive mutations and deletion of virulence genes. Method pioneered by Louis Pasteur for anthrax and rabies via passage in animals. For viral vaccines, poliovirus Sabin strains passaged in monkey kidney and mouse spinal cord selecting neurovirulence attenuating mutations in 5'UTR internal ribosome entry site reducing replication in neurons while retaining replication in gut. Measles Edmonston strain passaged in primary human kidney cells, chick embryo fibroblasts adaptation to avian receptors reducing human pathogenicity. BCG created by 230 serial passages of Mycobacterium bovis on potato bile glycerin medium 1908-1921 resulting loss of RD1 region encoding ESX-1 secretion system essential for virulence. Alternative modern strategies include cold adaptation growing influenza at 25°C selecting viruses replicating in cooler upper respiratory tract not warm lower lung, generation of reassortants, or reverse genetics deleting virulence genes like HSV ICP34.5. Attenuated microbe replicates limitedly presenting native antigens via both MHC pathways, inducing strong cellular immunity. Reversion monitored by sequencing.
Ref: Pasteur attenuation principle; Plotkin live vaccine passage; WHO Live attenuated methods.